151 related articles for article (PubMed ID: 8957074)
41. Down-regulation of fibronectin gene expression by the p53 tumor suppressor protein.
Iotsova V; Stehelin D
Cell Growth Differ; 1996 May; 7(5):629-34. PubMed ID: 8732672
[TBL] [Abstract][Full Text] [Related]
42. ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation.
Sgouras DN; Athanasiou MA; Beal GJ; Fisher RJ; Blair DG; Mavrothalassitis GJ
EMBO J; 1995 Oct; 14(19):4781-93. PubMed ID: 7588608
[TBL] [Abstract][Full Text] [Related]
43. Repression of Ets-2-induced transactivation of the tau interferon promoter by Oct-4.
Ezashi T; Ghosh D; Roberts RM
Mol Cell Biol; 2001 Dec; 21(23):7883-91. PubMed ID: 11689681
[TBL] [Abstract][Full Text] [Related]
44. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor.
Watabe T; Yoshida K; Shindoh M; Kaya M; Fujikawa K; Sato H; Seiki M; Ishii S; Fujinaga K
Int J Cancer; 1998 Jul; 77(1):128-37. PubMed ID: 9639404
[TBL] [Abstract][Full Text] [Related]
45. Tumor suppressor p53 inhibits transcriptional activation of invasion gene thromboxane synthase mediated by the proto-oncogenic factor ets-1.
Kim E; Günther W; Yoshizato K; Meissner H; Zapf S; Nüsing RM; Yamamoto H; Van Meir EG; Deppert W; Giese A
Oncogene; 2003 Oct; 22(49):7716-27. PubMed ID: 14586398
[TBL] [Abstract][Full Text] [Related]
46. CpG methylation has differential effects on the binding of YY1 and ETS proteins to the bi-directional promoter of the Surf-1 and Surf-2 genes.
Gaston K; Fried M
Nucleic Acids Res; 1995 Mar; 23(6):901-9. PubMed ID: 7731802
[TBL] [Abstract][Full Text] [Related]
47. Myb and Ets transcription factors cooperate at the myb-inducible promoter of the tom-1 gene.
Burk O; Klempnauer KH
Biochim Biophys Acta; 1999 Sep; 1446(3):243-52. PubMed ID: 10524199
[TBL] [Abstract][Full Text] [Related]
48. Identification and characterization of the IKKalpha promoter: positive and negative regulation by ETS-1 and p53, respectively.
Gu L; Zhu N; Findley HW; Woods WG; Zhou M
J Biol Chem; 2004 Dec; 279(50):52141-9. PubMed ID: 15469934
[TBL] [Abstract][Full Text] [Related]
49. Proteins of the ETS family with transcriptional repressor activity.
Mavrothalassitis G; Ghysdael J
Oncogene; 2000 Dec; 19(55):6524-32. PubMed ID: 11175368
[TBL] [Abstract][Full Text] [Related]
50. c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter.
Geng CD; Vedeckis WV
J Biol Chem; 2005 Dec; 280(52):43264-71. PubMed ID: 16263717
[TBL] [Abstract][Full Text] [Related]
51. Interaction between PU.1 and another Ets family transcription factor promotes macrophage-specific Basal transcription initiation.
Ross IL; Yue X; Ostrowski MC; Hume DA
J Biol Chem; 1998 Mar; 273(12):6662-9. PubMed ID: 9506963
[TBL] [Abstract][Full Text] [Related]
52. Ets-2 and components of mammalian SWI/SNF form a repressor complex that negatively regulates the BRCA1 promoter.
Baker KM; Wei G; Schaffner AE; Ostrowski MC
J Biol Chem; 2003 May; 278(20):17876-84. PubMed ID: 12637547
[TBL] [Abstract][Full Text] [Related]
53. The p53 tumor suppressor protein represses human snRNA gene transcription by RNA polymerases II and III independently of sequence-specific DNA binding.
Gridasova AA; Henry RW
Mol Cell Biol; 2005 Apr; 25(8):3247-60. PubMed ID: 15798209
[TBL] [Abstract][Full Text] [Related]
54. c-MYC repression of promoter activity through core promoter elements.
Lucas JM; Wilkie NM; Lang JC
Biochem Biophys Res Commun; 1993 Aug; 194(3):1446-52. PubMed ID: 8352803
[TBL] [Abstract][Full Text] [Related]
55. Regulation of urokinase expression in the developing avian heart: a role for the Ets-2 transcription factor.
Majka SM; McGuire PG
Mech Dev; 1997 Nov; 68(1-2):127-37. PubMed ID: 9431810
[TBL] [Abstract][Full Text] [Related]
56. ETS proteins and MMPs: partners in invasion and metastasis.
Singh S; Barrett J; Sakata K; Tozer RG; Singh G
Curr Drug Targets; 2002 Oct; 3(5):359-67. PubMed ID: 12182227
[TBL] [Abstract][Full Text] [Related]
57. TEL is a sequence-specific transcriptional repressor.
Lopez RG; Carron C; Oury C; Gardellin P; Bernard O; Ghysdael J
J Biol Chem; 1999 Oct; 274(42):30132-8. PubMed ID: 10514502
[TBL] [Abstract][Full Text] [Related]
58. Repression of interleukin-2 and interleukin-4 promoters by tumor suppressor protein p53.
Pesch J; Brehm U; Staib C; Grummt F
J Interferon Cytokine Res; 1996 Aug; 16(8):595-600. PubMed ID: 8877730
[TBL] [Abstract][Full Text] [Related]
59. Ets factors and regulation of the extracellular matrix.
Trojanowska M
Oncogene; 2000 Dec; 19(55):6464-71. PubMed ID: 11175362
[TBL] [Abstract][Full Text] [Related]
60. MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation.
Sieweke MH; Tekotte H; Frampton J; Graf T
Cell; 1996 Apr; 85(1):49-60. PubMed ID: 8620536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
